<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04013373</url>
  </required_header>
  <id_info>
    <org_study_id>IPD-HBHF-001</org_study_id>
    <nct_id>NCT04013373</nct_id>
  </id_info>
  <brief_title>Home-Based Fluid Status Monitoring in Heart Failure Patients</brief_title>
  <official_title>Home-Based Fluid Status Monitoring in Heart Failure Patients Recently Hospitalized for Acute Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ImpediMed Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ImpediMed Limited</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multi-center, single-arm study enrolling adult patients who have been&#xD;
      hospitalized for heart failure and subsequently discharged. For the duration of study&#xD;
      participation, patients will obtain daily at-home bioimpedance measurements. Heart failure&#xD;
      symptoms, medications, and re-hospitalizations will be tracked. Additionally, quality of life&#xD;
      questionnaires will be administered at the beginning and end of study participation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Covid-19 pandemic&#xD;
  </why_stopped>
  <start_date type="Actual">October 9, 2018</start_date>
  <completion_date type="Actual">July 30, 2021</completion_date>
  <primary_completion_date type="Actual">July 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serial bioimpedance spectroscopy (BIS) measurements including extracellular fluid and total body water</measure>
    <time_frame>45 days</time_frame>
    <description>Characterize BIS trends that precede hospital readmissions for heart failure</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">92</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>BIS home-based monitoring</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SOZO Bioimpedance Spectroscopy Device</intervention_name>
    <description>Bioimpedance spectroscopy measurements for assessment of fluid status</description>
    <arm_group_label>BIS home-based monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients who are being discharged home from a hospitalization for heart failure&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 21 years or older&#xD;
&#xD;
          2. NYHA Class II or III at the time of study enrollment&#xD;
&#xD;
          3. Undergoing discharge following hospitalization for acute heart failure&#xD;
&#xD;
          4. Planned continued treatment for heart failure&#xD;
&#xD;
          5. Patient is able to stand or sit upright for bioimpedance spectroscopy measurements&#xD;
&#xD;
          6. Patient reports access to reliable Wi-Fi connection at home&#xD;
&#xD;
          7. Patient reports adequate space for the SOZO device at home&#xD;
&#xD;
          8. Patient provides written informed consent and authorization to use and disclose health&#xD;
             information, including willingness to comply with study procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient has an implanted cardiac rhythm management device (pacemaker or implantable&#xD;
             cardioverter defibrillator)&#xD;
&#xD;
          2. Patient has a confirmed diagnosis of acute coronary syndrome during current admission&#xD;
&#xD;
          3. Patient is enrolled in a concurrent interventional study of an experimental treatment&#xD;
             that may confound the results of this study, in the investigator's opinion&#xD;
&#xD;
          4. Patient has a clinical condition that would not allow them to complete the study&#xD;
&#xD;
          5. Patient has had surgical revascularization using saphenous vein grafting that may&#xD;
             affect venous return&#xD;
&#xD;
          6. Patient is pregnant or lactating&#xD;
&#xD;
          7. Patient has nephrotic syndrome or nephrosis&#xD;
&#xD;
          8. Patient has end-stage renal disease requiring chronic dialysis&#xD;
&#xD;
          9. Patient has been diagnosed with lymphedema&#xD;
&#xD;
         10. Patient has chronic liver failure or cirrhosis&#xD;
&#xD;
         11. Patient has been diagnosed with thrombophlebitis or deep vein thrombosis in arms or&#xD;
             legs in the past 90 days&#xD;
&#xD;
         12. Patient has an amputation of a limb [Exception: amputation of digits may not affect&#xD;
             bioimpedance spectroscopy measurements and will be permitted at the discretion of the&#xD;
             study sponsor]&#xD;
&#xD;
         13. Patient has any other medical condition that, in the opinion of the investigator, will&#xD;
             impair the subject's ability to complete study procedures or participate in the&#xD;
             protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James T Heywood, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Scripps Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alliance Research Institute</name>
      <address>
        <city>Canoga Park</city>
        <state>California</state>
        <zip>91304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Du Cardiology</name>
      <address>
        <city>Encinitas</city>
        <state>California</state>
        <zip>92024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Diego Cardiovascular Associates</name>
      <address>
        <city>Encinitas</city>
        <state>California</state>
        <zip>92024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SC Clinical Research</name>
      <address>
        <city>Garden Grove</city>
        <state>California</state>
        <zip>92844</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scripps Clinic, John R. Anderson V Medical Pavilion</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MD Strategies Research Centers</name>
      <address>
        <city>National City</city>
        <state>California</state>
        <zip>91950</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Care Associates</name>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <zip>92056</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Blue Coast Cardiology</name>
      <address>
        <city>Vista</city>
        <state>California</state>
        <zip>92083</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Alliance</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Infinite Clinical Research</name>
      <address>
        <city>Doral</city>
        <state>Florida</state>
        <zip>33126</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>International Research Associates</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33183</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amavita Health</name>
      <address>
        <city>North Miami Beach</city>
        <state>Florida</state>
        <zip>33169</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Broward Research Center</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Flint Cardiovascular</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48532</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sierra Clinical Research</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 5, 2019</study_first_submitted>
  <study_first_submitted_qc>July 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

